Citigroup Forecasts Strong Price Appreciation for DuPont de Nemours (NYSE:DD) Stock

DuPont de Nemours (NYSE:DD – Get Free Report) had its target price upped by equities research analysts at Citigroup from $162.00 to $176.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the basic materials company’s stock. Citigroup‘s price objective indicates a potential upside of 16.44% from the stock’s current price.

DD has been the topic of a number of other research reports. Barclays raised their price objective on DuPont de Nemours from $156.00 to $176.00 and gave the stock an “overweight” rating in a research note on Wednesday. Royal Bank Of Canada cut their target price on DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a research report on Thursday, October 15th. UBS Group reduced their target price on DuPont de Nemours from $178.00 to $172.00 and set a “buy” rating on the stock in a report on Monday, October 5th. Zacks Research cut DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Friday. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, DuPont de Nemours has an average rating of “Moderate Buy” and a consensus price target of $164.12.

Read Our Latest Report on DD

DuPont de Nemours Stock Performance

Shares of DD traded down $2.31 during mid-day trading on Wednesday, hitting $151.15. 2,547,351 shares of the company’s stock were exchanged, compared to its average volume of 1,350,640. DuPont de Nemours has a 52 week low of $111.15 and a 52 week high of $157.98. The stock’s 50-day simple moving average is $132.64 and its 200-day simple moving average is $138.51. The firm has a market cap of $20.41 billion, a price-to-earnings ratio of 335.96, a price-to-earnings-growth ratio of 1.31 and a beta of 1.06. The company has a quick ratio of 1.82, a current ratio of 2.43 and a debt-to-equity ratio of 0.23.

DuPont de Nemours (NYSE:DD – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.22. The company had revenue of $1.87 billion during the quarter, compared to the consensus estimate of $1.84 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.09 earnings per share. On average, equities research analysts expect that DuPont de Nemours will post 7.25 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. State Street Corp grew its stake in shares of DuPont de Nemours by 140.3% in the second quarter. State Street Corp now owns 44,941,824 shares of the basic materials company’s stock worth $6,095,909,000 after purchasing an additional 26,238,300 shares during the last quarter. Groupe la Francaise acquired a new stake in DuPont de Nemours in the second quarter valued at $1,394,000. Farther Finance Advisors LLC raised its position in DuPont de Nemours by 839.5% during the 3rd quarter. Farther Finance Advisors LLC now owns 39,355 shares of the basic materials company’s stock worth $5,112,000 after purchasing an additional 35,166 shares during the last quarter. Vontobel Holding Ltd. bought a new position in DuPont de Nemours during the 3rd quarter worth $1,902,000. Finally, First Citizens Bank & Trust Co. lifted its holdings in DuPont de Nemours by 605.6% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 12,305 shares of the basic materials company’s stock worth $1,598,000 after buying an additional 10,561 shares during the period. 73.96% of the stock is currently owned by institutional investors and hedge funds.

More DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Q3 results topped expectations: DuPont reported adjusted EPS of $2.09 versus the $1.87 consensus and revenue of about $1.87 billion versus $1.84 billion expected. Sales rose 4% year over year, with organic sales up 5%. DuPont Reports Third Quarter 2026 Results
  • Positive Sentiment: Raised 2026 guidance: The company increased its full-year outlook again, citing strong demand in healthcare and aerospace. Its earnings release also highlighted robust cash generation, including $341 million in transaction-adjusted free cash flow. DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
  • Positive Sentiment: Share repurchases provide additional support: After completing substantial buybacks in Q3, DuPont said it intends to repurchase another $250 million of shares in Q4. DuPont Reports Third Quarter 2026 Results
  • Positive Sentiment: Barclays lifted its target: The firm raised its price target from $156 to $176 and reiterated an “overweight” rating, signaling confidence in further upside. Barclays stock recommendations
  • Neutral Sentiment: A report highlighted DuPont’s new peptide-purification product, but the available article headline provides limited detail on its expected financial contribution. What Is DuPont Signaling With Its New Peptide Purification Product?

About DuPont de Nemours

(Get Free Report)

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

See Also

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.